<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:   X-ray Microscope for In-Vivo Biological Imaging</AwardTitle>
<AwardEffectiveDate>02/01/2005</AwardEffectiveDate>
<AwardExpirationDate>01/31/2007</AwardExpirationDate>
<AwardTotalIntnAmount>494620.00</AwardTotalIntnAmount>
<AwardAmount>494620</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>F.C. Thomas Allnutt</SignBlockName>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase II project aims to develop a sub-micron x-ray tomography scanner  capable of providing in-vivo and high resolution images of specimens from mice to bacteria. In this era of molecular medicine, where disease and developmental disorders are being re-defined by  their  peculiar  molecular,  genetic  or  cellular  profiles,  there  exists  a  significant  disparity  between  the  type  of  information  gleaned  from  histological  methods  and  that  obtained  from conventional non-invasive imaging modalities.  With a resolution that is better than these imaging  modalities and more than ten times higher than that of current x-ray imaging systems, the proposed  device  will generate  images  of  development  and  disease  not  possible  by  current  methods.    The Phase II  research  will  concentrate  on  the  development  of  the  x-ray optical system, including beam conditioning, tomographic imaging capability, and the imaging x-ray lens, and will result in a table-top commercial prototype computerized tomographic imager with 400 nm resolution.  &lt;br/&gt; &lt;br/&gt;The commercial application of this project will be in the area of medical research. When compared to existing in-vivo imaging technologies, the higher resolution of the proposed  x-ray  imager  will  translate  to  improved  sensitivity  and  specificity  of  morphologic changes  associated  with  growth  and  disease.  Researchers  will  be  able  to  use  this  tool  for  investigations of a number of medical conditions, including tumor angiogenesis, atherosclerosis, osteoporosis and arthritis.&lt;br/&gt; &lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>01/26/2005</MinAmdLetterDate>
<MaxAmdLetterDate>01/26/2005</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0450518</AwardID>
<Investigator>
<FirstName>Charles</FirstName>
<LastName>Gary</LastName>
<EmailAddress>cgary@adelphitech.com</EmailAddress>
<StartDate>01/26/2005</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Adelphi Technology, Inc</Name>
<CityName>Redwood City</CityName>
<ZipCode>940634121</ZipCode>
<PhoneNumber>6504742750</PhoneNumber>
<StreetAddress>2003 East Bayshore Rd</StreetAddress>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
</Institution>
<FoaInformation>
<Code>0203000</Code>
<Name>Health</Name>
</FoaInformation>
<FoaInformation>
<Code>0510402</Code>
<Name>Biomaterials-Short &amp; Long Terms</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>9148</Code>
<Text>TOOLS &amp; TECHNOL FOR MANUFACTURING DESIGN</Text>
</ProgramReference>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
</Award>
</rootTag>
